NCT06336317View on ClinicalTrials.gov

Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Acute Myocardial InfarctionCardiovascular DiseasesInflammatory Response
Interventions
BIOLOGICAL

Influenza vaccine

VaxigripTetra Suspension for injection, 0,5ml prefilled syringe ATC code: J07BB02

BIOLOGICAL

Placebo

Sodium Chloride Solution for infusion, 9mg/ml ATC code: B05BB01

Trial Locations (1)

70185

RECRUITING

Örebro University Hospital, Örebro

All Listed Sponsors
collaborator

The Swedish Heart and Lung Association

OTHER

collaborator

Örebro University, Sweden

OTHER

collaborator

University of Cambridge

OTHER

lead

Region Örebro County

OTHER